FOR IMMEDIATE RELEASE

Roboangio: Redefining Vascular Interventions

Abrobo Product and Design Center proudly presents Roboangio, an advanced interventional robotic system that aims to transform the landscape of vascular surgeries. The incidence of vascular diseases has been steadily increasing worldwide, presenting significant challenges for physicians. Traditional interventional surgeries often expose physicians to high levels of radiation and pose the risk of manual errors, limiting the accessibility of effective treatments for numerous patients.

Roboangio, developed in collaboration with clinical experts, addresses these challenges by offering a master-slave control solution that enables physicians to perform remote delivery and manipulation of guidewires and catheters during vascular interventional surgeries. This innovative approach allows physicians to operate in a radiation-free environment while maintaining complete control, enhancing safety for both medical professionals and patients.

With its intuitive interaction and robotic precision, Roboangio streamlines the surgical process, providing ease for physicians and ensuring the safety and well-being of patients. The system's design represents a significant leap forward in interventional robotic technology, offering a solution that combines cutting-edge innovation with practical functionality.

The development of Roboangio commenced in March 2021, with extensive research and clinical trials leading to its public release in October 2023. Designed and manufactured in Shenzhen, Guangdong, China, the project underwent rigorous R&D activities, including formative and summative tests, to ensure its compliance with regulatory standards and the fulfillment of clinical needs.

Overcoming multidisciplinary challenges in electromechanical integration, control algorithms, and aseptic manufacturing techniques, the design team successfully realized the vision of empowering interventional surgery with robotic technology. The system's unique properties and strengths lie in its ability to seamlessly integrate into existing surgical environments, providing physicians with familiar operating tools and techniques while leveraging the benefits of robotic assistance.

Abrobo's commitment to user-centered product development has resulted in the creation of Roboangio, a groundbreaking interventional robotic system that has garnered recognition and accolades, including the prestigious Silver A' Design Award in 2024. With over 460 pieces of intellectual property, Abrobo continues to lead the way in the industrialization of interventional robotic technology, setting new standards for excellence and innovation in the field.

-END-